Used as a key intermediate in the synthesis of kinase inhibitors for targeted cancer therapies. Particularly valuable in the development of compounds that modulate signaling pathways involved in tumor growth and proliferation. Its structure allows selective modification to enhance binding affinity and specificity toward protein kinases such as JAK and EGFR. Commonly employed in medicinal chemistry research for optimizing lead compounds in oncology drug discovery programs. Also utilized in the preparation of biologically active molecules for studying cellular signaling mechanisms.